Browsing by Author Baron-Hay, Sally

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
PreviewIssue DateTitle / NameAuthor(s)Type
2022CDK4/6 Inhibitors (CKD4/6i) in advanced hormone-receptor-positive (HR+) HER2-negative (HER2-) breast cancer: Prescribing practices and outcomes in a real-world, Australian cohortJavaid, Anadil; Lok, Sheau Wen; Wong, Vanessa; Baron-Hay, Sally; Boyle, Fran, et alConference Paper 
2015Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC).Khasraw, Mustafa; Mukaro, Violet; West, Linda; Brandt, Conrad; Woollett, Anne Maree, et alConference Paper 
PLOS ONE - 2019 - Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer The phase II NEONAB trial-Clinical outcomes and molecular determinants of response.pdf.jpg2019Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of responseMurphy, Caitlin; Muscat, Andrea; Ashley, David; Mukaro, Violet; West, Linda, et alJournal Article